References
Austin LA, Heath H, Go VLW (1979) Regulation of calcitonin secretion in normal man by changes of serum calcium within the physiologic range. J Clin Invest 64:1721–1724
Cohn SH, Hauser DW, Klopper J, Atkins HL (1971) Effects of porcine calcitonin on calcium metabolism in osteoporosis. J Clin Endocrinol Metab 33:719–728
Chapuy MC, Meunier P, Terrier M, David L, Vignon G (1975) Effects biologiques a court terme de la calcitonine synthetique de saumon dans la maladie de Paget. Pathol Biol (Paris) 23:349–359.
Jowsey J, Riggs BL, Goldsmith RS, Kelly PJ, Arnaud CD (1971) Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis. J Clin Endocrinol Metab 33:752–758
Rico H, Huertas R, Gomez-Castresana F, Espinos D (1982) Calcitonina y calcio en el tratamiento de la enfermedad osea de paget. Med Clin (Barcelona) 78:179–182.
Handy R, Neil A, Gubbens G, Vinson M, Nishet J, Exxon-Smith AN (1984) Hypocalcemic response following calcitonin administration to patients with osteoporosis. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, peck WA, Riggs BL (eds) Osteoporosis I. Aalborg Stiftsboytrykkeri Denmark, pp 149–151
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rico, H. The use of calcitonin as antiosteolytic drug. Calcif Tissue Int 37, 105–106 (1985). https://doi.org/10.1007/BF02554826
Issue Date:
DOI: https://doi.org/10.1007/BF02554826